BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 20718743)

  • 1. Regional enhancement of cannabinoid CB₁ receptor desensitization in female adolescent rats following repeated Delta-tetrahydrocannabinol exposure.
    Burston JJ; Wiley JL; Craig AA; Selley DE; Sim-Selley LJ
    Br J Pharmacol; 2010 Sep; 161(1):103-12. PubMed ID: 20718743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex, THC, and hormones: Effects on density and sensitivity of CB
    Farquhar CE; Breivogel CS; Gamage TF; Gay EA; Thomas BF; Craft RM; Wiley JL
    Drug Alcohol Depend; 2019 Jan; 194():20-27. PubMed ID: 30391834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAAH-/- mice display differential tolerance, dependence, and cannabinoid receptor adaptation after delta 9-tetrahydrocannabinol and anandamide administration.
    Falenski KW; Thorpe AJ; Schlosburg JE; Cravatt BF; Abdullah RA; Smith TH; Selley DE; Lichtman AH; Sim-Selley LJ
    Neuropsychopharmacology; 2010 Jul; 35(8):1775-87. PubMed ID: 20357755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
    Craft RM; Wakley AA; Tsutsui KT; Laggart JD
    J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chronic administration of R-(+)-[2,3-Dihydro-5-methyl-3-[(morpholinyl)methyl]pyrrolo[1,2,3-de]-1,4-benzoxazinyl]-(1-naphthalenyl)methanone mesylate (WIN55,212-2) or delta(9)-tetrahydrocannabinol on cannabinoid receptor adaptation in mice.
    Sim-Selley LJ; Martin BR
    J Pharmacol Exp Ther; 2002 Oct; 303(1):36-44. PubMed ID: 12235230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.
    Nguyen PT; Schmid CL; Raehal KM; Selley DE; Bohn LM; Sim-Selley LJ
    Biol Psychiatry; 2012 Apr; 71(8):714-24. PubMed ID: 22264443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delta FosB and AP-1-mediated transcription modulate cannabinoid CB₁ receptor signaling and desensitization in striatal and limbic brain regions.
    Lazenka MF; David BG; Lichtman AH; Nestler EJ; Selley DE; Sim-Selley LJ
    Biochem Pharmacol; 2014 Oct; 91(3):380-9. PubMed ID: 25093286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ΔFosB induction correlates inversely with CB₁ receptor desensitization in a brain region-dependent manner following repeated Δ⁹-THC administration.
    Lazenka MF; Selley DE; Sim-Selley LJ
    Neuropharmacology; 2014 Feb; 77():224-33. PubMed ID: 24090766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol.
    Wise LE; Thorpe AJ; Lichtman AH
    Neuropsychopharmacology; 2009 Aug; 34(9):2072-80. PubMed ID: 19322169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term behavioral and pharmacodynamic effects of delta-9-tetrahydrocannabinol in female rats depend on ovarian hormone status.
    Winsauer PJ; Daniel JM; Filipeanu CM; Leonard ST; Hulst JL; Rodgers SP; Lassen-Greene CL; Sutton JL
    Addict Biol; 2011 Jan; 16(1):64-81. PubMed ID: 21158010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol.
    McKinney DL; Cassidy MP; Collier LM; Martin BR; Wiley JL; Selley DE; Sim-Selley LJ
    J Pharmacol Exp Ther; 2008 Feb; 324(2):664-73. PubMed ID: 17967938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissimilar cannabinoid substitution patterns in mice trained to discriminate Δ(9)-tetrahydrocannabinol or methanandamide from vehicle.
    Wiley JL; Matthew Walentiny D; Vann RE; Baskfield CY
    Behav Pharmacol; 2011 Sep; 22(5-6):480-8. PubMed ID: 21712709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic-induced alterations in CB1 receptor-mediated G-protein signaling and in vivo pharmacology in rats.
    Wiley JL; Kendler SH; Burston JJ; Howard DR; Selley DE; Sim-Selley LJ
    Neuropharmacology; 2008 Dec; 55(7):1183-90. PubMed ID: 18708079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.
    Smith PA; Selley DE; Sim-Selley LJ; Welch SP
    Eur J Pharmacol; 2007 Oct; 571(2-3):129-37. PubMed ID: 17603035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant.
    Justinova Z; Munzar P; Panlilio LV; Yasar S; Redhi GH; Tanda G; Goldberg SR
    Neuropsychopharmacology; 2008 Nov; 33(12):2870-7. PubMed ID: 18305459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strain and sex differences in puberty onset and the effects of THC administration on weight gain and brain volumes.
    Keeley RJ; Trow J; McDonald RJ
    Neuroscience; 2015 Oct; 305():328-42. PubMed ID: 26186896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats.
    Moore NL; Greenleaf AL; Acheson SK; Wilson WA; Swartzwelder HS; Kuhn CM
    J Pharmacol Exp Ther; 2010 Nov; 335(2):294-301. PubMed ID: 20668056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific alterations in hippocampal cannabinoid 1 receptor expression following adolescent delta-9-tetrahydrocannabinol treatment in the rat.
    Silva L; Harte-Hargrove L; Izenwasser S; Frank A; Wade D; Dow-Edwards D
    Neurosci Lett; 2015 Aug; 602():89-94. PubMed ID: 26118897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
    Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
    Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.